Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Fate Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Fate Therapeutics Inc. June 6, 202385.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 19, 2023 | Fate Therapeutics Inc. | Option exercise | +28,461 | $1.37 | $38,992 |
| Jan 13, 2023 | Fate Therapeutics Inc. | Open-market purchase | +36,631 | $5.43 | $198,906 |
| Jan 11, 2023 | Fate Therapeutics Inc. | Open-market purchase | +88,048 | $5.67 | $499,232 |
Questions about John Mendlein
What boards is John Mendlein on?
John Mendlein sits on the board of Fate Therapeutics Inc.
How long has John Mendlein served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.